Nov 07, 2022 / 09:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Singular Genomics Systems, Inc. Third Quarter 2022 Earnings Conference Call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Philip Taylor, Investor Relations for Singular Genomics. Sir, the floor is yours.
Philip Taylor - Gilmartin Group LLC - Associate
Thank you, operator. Presenting today are singular Genomics Founder and Chief Executive Officer, Drew Spaventa; and Chief Financial Officer, Dalen Meeter.
Earlier today, Singular Genomics released financial results for the 3 months ended September 30, 2022. A copy of the press release is available on the company's website. Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, November 7, 2022, only and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations and other information related to our financial and operating results, plans and strategies.
Actual
Q3 2022 Singular Genomics Systems Inc Earnings Call Transcript
Nov 08, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers